SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Cue Health to Sell 12 Million Shares in IPO

Cue Health will offer 12.5 million common shares for a range of $15 to $17 per share, according to its amended IPO.

Advanced BioMatrix Acquired for $15 Million

BIOTECH: San Diego Co. Joins BICO’s Bioprinting Business

Advanced BioMatrix, a San Diego biotech that creates products for 3D applications including cell cultivation, cell assays and bioprinting, was acquired by BICO Group AB (STO: BICO) for approximately $15 million.

Scientist.com Acquires InsideScientific

Scientist.com expands its offerings of "biotech as a service” (BaaS) platform

Tease photo

ARS Pharma Raises $55M

MEDICINE: Funding Backs Product Launch

ARS Pharmaceuticals, a pre-commercial pharmaceutical company, raised $55 million in Series D funding to back preparations for the launch of its lead product Neffy, an epinephrine nasal spray.

iBio to Grow Talent in S.D.

BIOTECH: Co. Develops Plant-Based Therapies

iBio, Inc. (NYSEA: IBIO), a company that produces plant-based antibodies for therapeutics and vaccines, has joined the growing number of life science companies choosing to expand their operations in San Diego.

Tease photo

Codex DNA Releases Full-Length Synthetic Genome for Highly Infectious SARS-CoV-2 Delta Variant

Codex DNA released full-length synthetic genome of COVID-19 Delta variant virus.

Cue Health Files for IPO

Cue Health filed an initial public offering on Sept. 1.

Poseida Therapeutics Announces FDA Clearance of Investigational New Drug Application

FDA clears the company's first fully allogeneic CAR-T product candidate for patients with relapsed/refractory multiple myeloma.

Advanced BioMatrix Acquired by BICO for $15M

San Diego-based Advanced BioMatrix acquired for $15 million.

NuVasive’s Q2 Earnings Up 45%

BIOTECH: Co. Increases Investment in R&D

San Diego medical device company, NuVasive (NASDAQ: NUVA) recorded $294.8 million in net sales for the second quarter 2021 — a 44.8% increase from the previous year’s same period.

Tease photo

BioSurplus in 3-Way Merger

BIOTECH: Co. Formed As One-Stop-Shop

Local life science company, BioSurplus, joined Massachusetts-based Biodirect and Boston Microscopes in a three-way merger to form Copia Scientific.

The Conrad Prebys Foundation Approves $1M Grant for Tri-City Hospital

Tri-City Medical Center is home to acclaimed emergency room-based programs in heart attack and stroke care.

INOVIO Gets Authorization for Phase 3 Trials of COVID-19 Vaccine Candidate

BIOTECH: Brazil’s Regulatory Agency Gives the Co. Green Light

INOVIO received authorization from Brazil's ANVISA (Agência Nacional de Vigilância Sanitária) to initiate a global Phase 3 efficacy trial for INO-4800, its DNA vaccine candidate for COVID-19.

Artiva Biotherapeutics Announces New San Diego Facility

BIOTECH: R&D and GMP Manufacturing Center to Open in 2022

Artiva Biotherapeutics, a clinical-stage biotech company developing off-the-shelf, allogeneic, natural killer (NK) cell-based therapies, will establish a 52,000 square foot research and manufacturing center at its San Diego headquarters.

Tease photo

ResMed Reports $3.2 Billion in Revenue

BIOTECH: Demand Growing; New Product Launched

ResMed, the leading global manufacturer in sleep apnea therapy, reported their Q4 earnings on Aug. 5 and recorded $876.1 million in revenue.

Tease photo

Prev